<DOC>
	<DOCNO>NCT02928991</DOCNO>
	<brief_summary>This pilot study determine whether fludarabine-based reduced intensity conditioning ( RIC ) regimens facilitate successful donor engraftment patient acquire aplastic anemia ( AA ) Inherited bone marrow failure ( iBMF ) syndromes undergo Matched related donor bone marrow transplant ( MRD-BMT ) .</brief_summary>
	<brief_title>Fludarabine Based RIC Bone Marrow Failure Syndromes</brief_title>
	<detailed_description>Acquired AA patient receive experimental regimen fludarabine dose-reduced cyclophosphamide , result prospective single arm experimental group evaluate context institutional historical experience use HD Cy regimens well publish outcome use fludarabine high-dose cyclophosphamide-based regimen MRD-BMT aplastic anemia . iBMF syndrome patient receive one two fludarabine-containing regimen base disease characteristic , outcome compare previously publish data use variety regimen . Graft versus host disease ( GvHD ) prophylaxis consist cyclosporine/tacrolimus alone patient acquire AA cyclosporine/tacrolimus plus mycophenolate patient iBMF syndrome . For acquire AA iBMF syndrome patient , donor chimerism assess schedule interval follow BMT use define patient full donor mixed chimerism comparison survival , graft failure , cytogenetic , GvHD , immune reconstitution outcome .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Pancytopenia</mesh_term>
	<mesh_term>Hemoglobinuria , Paroxysmal</mesh_term>
	<mesh_term>Cyclophosphamide</mesh_term>
	<mesh_term>Fludarabine phosphate</mesh_term>
	<mesh_term>Fludarabine</mesh_term>
	<mesh_term>Vidarabine</mesh_term>
	<criteria>Patients 022 year acquire aplastic anemia diagnose inherited bone marrow failure syndrome , fully Human leukocyte antigen ( HLA ) match ( 10/10 ) relate donor . Patient : 1 . Ages 022 year time enrollment 2 . Diseases : Patients severe severe acquire AA , define : Bone marrow biopsy demonstrate cellularity &lt; 25 % ( least 2 week last dose GCSF ) , addition 2 following : absolute neutrophil count ( ANC ) &lt; 500/µL , platelet &lt; 20,000/µL absolute reticulocyte &lt; 40,000/µL Negative evaluation inherit bone marrow failure condition negative evaluation dysplasia cytogenetic abnormality associate myelodysplastic syndrome Patients concurrent paroxysmal nocturnal hemoglobinuria ( PNH ) clone eligible , long meet criterion severe severe aplastic anemia define Patients clinically diagnose and/or genetically proven iBMF syndrome , result chronic red blood cell platelettransfusion dependence and/or absolute neutrophil count &lt; 500/µL . These disorder include , limited : Fanconi Anemia Dyskeratosis Congenita Severe Congenital Neutropenia DiamondBlackfan Anemia Congenital Dyserythropoietic/Sideroblastic Anemias Congenital Amegakaryocytic Thrombocytopenia ShwachmanDiamond Syndrome 3 . Lansky Karnofsky performance &gt; 60 4 . HLA match related donor available . 5 . No active untreated infection 6 . Females childbearing potential must negative pregnancy test . Organ Function : Serum creatinine &lt; 1.5xupper limit normal age Hepatic : Transaminases &lt; 5x normal Cardiac shorten fraction &gt; 27 % Bilirubin &lt; 2.5x normal ( unless elevation due Gilberts disease ) . Donor Selection Criteria : Donor selection comply U.S. Food Drug Administration 's Code Federal Regulations Fully HLAmatched relate donor . Donor must least 6 month age Donor suitable bone marrow collection meet eligibility donation , include fulfil infectious disease criterion per SOP , include HIV , Hepatitis B , Hepatitis C Polymerase chain reaction ( PCR ) negative . If subject confirm iBMF syndrome , donor must evaluate disorder test must negative Children 's Hospital Philadelphia ( CHOP ) bone marrow transplant ( BMT ) procedures apply determine donor eligibility , include donor screen test relevant communicable disease agent diseases . Donor evaluation collection procedure per CHOP Standard Operating Procedures ( SOP ) Uncontrolled bacterial , viral fungal infection HLA match related donor unable donate bone marrow . No eligible fully HLAmatched relate donor Pregnant females Patients clinical diagnosis Myelodysplastic syndrome ( MDS ) define combination bone marrow dysplasia classic cytogenetic lesion ( Monosomy 7 , Trisomy 8 eg . ) , without excess blast . Patients PNH without underlie bone marrow aplasia</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>22 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Acquired aplastic anemia</keyword>
	<keyword>Inherited bone marrow failure</keyword>
</DOC>